African Female Breast Cancer Epidemiology Study (AFBRECANE)
The AFBRECANE study, a part of the Human Heredity and Health in Africa (H3Africa) initiative, was designed to study the genomics and epidemiology of breast cancer and its molecular subtypes in Nigerian women. The study linked recruitment of breast cancer cases at study sites with population-based cancer registry activities. This enabled ascertainment of the incidence of breast cancer and its molecular subtypes. The cases in this study were women aged 18 years and older with clinical and histological diagnosis of breast cancer. Enrollment commenced in November 2018 at National Hospital Abuja and University of Abuja Teaching Hospital Gwagwalada in central Nigeria, University College Hospital Ibadan in Western Nigeria, and University of Nigeria Teaching Hospital, Enugu in Eastern Nigeria.
Study design
Cohort - clinical
Number of participants at first data collection
1,000 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
Female
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2018
Primary Institutions
National Institutes of Health (NIH)
University of Maryland, College Park (UMD)
University of Nigeria Teaching Hospital
Profile paper DOI
Funders
National Cancer Institute (NCI)
National Human Genome Research Institute (NHGRI)
National Institutes of Health (NIH)
Ongoing?
Yes
Data types collected
- Interview – face-to-face
- Secondary data
- Self-report questionnaire – paper or computer assisted
- None
- None
- Existing research data
- Healthcare data
Engagement
Keywords
Consortia and dataset groups
